June was a busy month for the FDA with the approval of two gene therapies, Elevidys (delandistrogene moxeparvovec-rokl) and Roctavian (valoctocogene roxaparvovec-rvox), and one cellular therapy Lantidra (donislecel-jujn).
6920 Pointe Inverness Way, Suite 140
Fort Wayne, IN, 46804
2604073977
